NIH Funding · FY2024
Total Funding
$1.7M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#7,359
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $1.7M across 3 grants · National rank #7359.
Top grants by award amount
Ozgur Sahin's NIH grant portfolio, ranked by award amount.
- 4R42CA275622-02R42Developing novel LOX inhibitors to target chemotherapy resistant TNBC$992.9Kaward amount
- 5R01CA267101-04R01Overcoming chemoresistance in triple negative breast cancer$352.3Kaward amount
- 5R01CA251374-04R01Inhibiting tumor growth and metastasis in highly aggressive breast cancers with centrosome amplification$321.8Kaward amount
Affiliations
Institutions that have administered grants for Ozgur Sahin.
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardLoxigen, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7359
- 2024Multi-Institutional ResearchAwards at 2 institutions
Explore further
Find collaborators for Ozgur Sahin
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Loxigen, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →